TP53 and cancer: In humans, the finding of highly recurrent activating mutations in the hTERT gene promoter [1], together with widespread p53 mutations in cancer [62], provide support for the idea that circumvention of a telomere-p53 checkpoint is also essential for carcinogenesis in humans.